促红细胞生成素；关于当前知识和新概念的综述
Erythropoietin; a review on current knowledge and new concepts.
作者信息
Tamadon Mohamad-Reza, Beladi-Mousavi Seyed Seifollah
机构信息
Department of Internal Medicine, Semnan University of Medical Sciences, Semnan, Iran.
Department of Internal Medicine, Ahvaz Jundishapour University of Medical Sciences, Ahvaz, Iran.
出版信息
J Renal Inj Prev. 2013 Oct 10;2(4):119-21. doi: 10.12861/jrip.2013.38. eCollection 2013.
Abstract
Chronic kidney disease (CKD) is a worldwide health problem. However, despite to new routes of dialysis, mortality and morbidity is high. One of the most common symptom of CKD is anemia, especially is more obvious in stages 3 and 4. In this review, we compared the effects of erythropoietin and anemia correction on kidney function (GFR) by investigating in various studies. Despite extensive studies in this category, still we do not sure about the effects of erythropoietin and anemia correction on the glomerular filtration rate.
摘要
慢性肾脏病（CKD）是一个全球性的健康问题。然而，尽管有了新的透析途径，死亡率和发病率仍然很高。CKD最常见的症状之一是贫血，尤其是在3期和4期更为明显。在本综述中，我们通过研究各项研究来比较促红细胞生成素和纠正贫血对肾功能（肾小球滤过率）的影响。尽管对此类进行了广泛研究，但我们仍不确定促红细胞生成素和纠正贫血对肾小球滤过率的影响。
相似文献
1
Erythropoietin; a review on current knowledge and new concepts.促红细胞生成素；关于当前知识和新概念的综述
J Renal Inj Prev. 2013 Oct 10;2(4):119-21. doi: 10.12861/jrip.2013.38. eCollection 2013.
2
Renal anemia and hydration status in non-dialysis chronic kidney disease: Is there a link?非透析慢性肾脏病患者的肾性贫血与水化状态：二者有关联吗？
J Med Life. 2018 Oct-Dec;11(4):293-298. doi: 10.25122/jml-2019-0002.
3
Attitude of physicians in Saudi Arabia towards anemia treatment strategies in patients with chronic kidney disease.沙特阿拉伯医生对慢性肾病患者贫血治疗策略的态度。
Saudi J Kidney Dis Transpl. 2007 Mar;18(1):65-72.
4
2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.2008年日本透析治疗学会：慢性肾脏病肾性贫血指南
Ther Apher Dial. 2010 Jun;14(3):240-75. doi: 10.1111/j.1744-9987.2010.00836.x.
5
Stabilization of glomerular filtration rate in advanced chronic kidney disease: a two-year follow-up of a cohort of chronic kidney disease patients stages 4 and 5.晚期慢性肾脏病患者肾小球滤过率的稳定：对4期和5期慢性肾脏病患者队列的两年随访
Adv Chronic Kidney Dis. 2007 Jan;14(1):105-12. doi: 10.1053/j.ackd.2006.07.009.
6
Epidemiology of chronic kidney disease and anemia.慢性肾脏病与贫血的流行病学
J Am Med Dir Assoc. 2006 Nov;7(9 Suppl):S3-6; quiz S17-21. doi: 10.1016/j.jamda.2006.09.004.
7
Influence of the 6-month anemia therapy with erythropoietin on renal function and some hemodynamic parameters in predialysis patients.促红细胞生成素6个月贫血治疗对透析前患者肾功能及一些血流动力学参数的影响。
Pol Arch Med Wewn. 2009 Jan-Feb;119(1-2):45-51.
8
[Clinical relevance of anemia treatment in patients with chronic kidney disease].[慢性肾脏病患者贫血治疗的临床相关性]
Acta Med Croatica. 2012 Jul;66(3):193-202.
9
Methoxy Polyethylene Glycol-Epoetin Beta as a Novel Erythropoiesis Stimulating Agent with Possible Nephroprotective and Cardiovascular Protective Effects in Non-Dialysis Chronic Kidney Disease Patients.甲氧基聚乙二醇-促红细胞生成素β作为一种新型促红细胞生成刺激剂，对非透析慢性肾脏病患者可能具有肾脏保护和心血管保护作用。
Curr Pharm Biotechnol. 2017;18(4):303-308. doi: 10.2174/1389201018666170127104801.
10
The role of comprehensive renal clinic in chronic kidney disease stabilization and management: The Northwestern experience.综合肾脏诊所在慢性肾脏病稳定与管理中的作用：西北大学的经验。
Semin Nephrol. 2002 Nov;22(6):526-32. doi: 10.1053/snep.2002.35970.
引用本文的文献
1
Pulmonary hypertension among patients undergoing hemodialysis.接受血液透析患者中的肺动脉高压
J Renal Inj Prev. 2016 Dec 4;6(2):122-126. doi: 10.15171/jrip.2017.24. eCollection 2017.
2
Prevalence and predictors of atherosclerotic renal artery stenosis in hypertensive patients undergoing simultaneous coronary and renal artery angiography; a cross-sectional study.同时接受冠状动脉和肾动脉血管造影的高血压患者中动脉粥样硬化性肾动脉狭窄的患病率及预测因素；一项横断面研究。
J Renal Inj Prev. 2016 Feb 18;5(1):34-8. doi: 10.15171/jrip.2016.08. eCollection 2016.
3
Contrast induced nephropathy among patients with normal renal function undergoing coronary angiography.冠状动脉造影检查的肾功能正常患者中对比剂诱导的肾病
J Renal Inj Prev. 2016 Feb 26;5(1):21-4. doi: 10.15171/jrip.2016.05. eCollection 2016.
4
Arteriovenous Fistula Recirculation in Hemodialysis.血液透析中的动静脉内瘘再循环
Nephrourol Mon. 2015 Jul 22;7(4):e27474. doi: 10.5812/numonthly.27474. eCollection 2015 Jul.
5
Diabetes and end-stage renal disease; a review article on new concepts.糖尿病与终末期肾病；一篇关于新概念的综述文章
J Renal Inj Prev. 2015 Jun 1;4(2):28-33. doi: 10.12861/jrip.2015.07. eCollection 2015.
6
Protective effects of metformin on renal tubular cells.二甲双胍对肾小管细胞的保护作用。
Iran Red Crescent Med J. 2014 Sep 5;16(9):e11662. doi: 10.5812/ircmj.11662. eCollection 2014 Sep.
7
Erythropoietin and renal protection.促红细胞生成素与肾脏保护
Daru. 2013 Dec 20;21(1):78. doi: 10.1186/2008-2231-21-78.
本文引用的文献
1
Erythropoietin ameliorates genetamicin-induced renal toxicity: A biochemical and histopathological study.促红细胞生成素改善庆大霉素诱导的肾毒性：一项生化和组织病理学研究。
J Nephropathol. 2012 Jul;1(2):109-16. doi: 10.5812/nephropathol.7533. Epub 2012 Jul 1.
2
Erythropoietin; bright future and new hopes for an old drug.促红细胞生成素：一种老药的光明未来与新希望
J Nephropathol. 2012 Jul;1(2):81-2. doi: 10.5812/nephropathol.7475. Epub 2012 Jul 1.
3
Influence of the 6-month anemia therapy with erythropoietin on renal function and some hemodynamic parameters in predialysis patients.促红细胞生成素6个月贫血治疗对透析前患者肾功能及一些血流动力学参数的影响。
Pol Arch Med Wewn. 2009 Jan-Feb;119(1-2):45-51.
4
In vivo and in vitro effects of simvastatin on inflammatory markers in pre-dialysis patients.辛伐他汀对透析前患者炎症标志物的体内和体外作用
Nephrol Dial Transplant. 2006 Feb;21(2):337-44. doi: 10.1093/ndt/gfi224. Epub 2005 Oct 25.
5
Renal function, erythropoietin, and anemia of older persons: the InCHIANTI study.老年人的肾功能、促红细胞生成素与贫血：InCHIANTI研究
Arch Intern Med. 2005 Oct 24;165(19):2222-7. doi: 10.1001/archinte.165.19.2222.
6
Effects of atorvastatin on low-density lipoprotein cholesterol phenotype and C-reactive protein levels in patients undergoing long-term dialysis.阿托伐他汀对长期透析患者低密度脂蛋白胆固醇表型及C反应蛋白水平的影响
Pharmacotherapy. 2005 Mar;25(3):335-44. doi: 10.1592/phco.25.3.335.61599.
7
Effects of atorvastatin on triglyceride-rich lipoproteins, low-density lipoprotein subclass, and C-reactive protein in hemodialysis patients.阿托伐他汀对血液透析患者富含甘油三酯的脂蛋白、低密度脂蛋白亚类及C反应蛋白的影响
Metabolism. 2004 Sep;53(9):1113-7. doi: 10.1016/j.metabol.2004.01.011.
8
The effect of statins versus untreated dyslipidaemia on renal function in patients with coronary heart disease. A subgroup analysis of the Greek atorvastatin and coronary heart disease evaluation (GREACE) study.他汀类药物与未治疗的血脂异常对冠心病患者肾功能的影响。希腊阿托伐他汀与冠心病评估（GREACE）研究的亚组分析。
J Clin Pathol. 2004 Jul;57(7):728-34. doi: 10.1136/jcp.2003.012989.
9
Update on interleukin-6 and its role in chronic renal failure.
Nephrol Dial Transplant. 2003 Jun;18(6):1042-5. doi: 10.1093/ndt/gfg111.
10
Mortality, malnutrition, and atherosclerosis in ESRD: what is the role of interleukin-6?终末期肾病中的死亡率、营养不良与动脉粥样硬化：白细胞介素-6起什么作用？
Kidney Int Suppl. 2002 May(80):103-8. doi: 10.1046/j.1523-1755.61.s80.19.x.
Zotero 插件